Regeneron Pharmaceuticals (REGN)

The anti-Wolf of Wall Street, Cathie Wood brings honesty and integrity to the world of high finance. Her strong track record confirms that nice folks can finish first.

3 Under-the-Radar Biotech Stocks to Buy After Dull Earnings Reactions

By Nicolas Chahine, InvestorPlace Contributor Feb 8, 2021

Investors are enamored with high profile stocks and ignoring ones that are solid investments. Here are three biotech stocks to consider.

4 Top Stock Trades for Monday: F, CLX, REGN, LKNCY

By Bret Kenwell, InvestorPlace Contributor Feb 5, 2021

Ford, Clorox, Regeneron and Luckin Coffee were our top stock trades for Monday. Let's get a look at the charts as we head into next week.

7 Safe Growth Stocks to Put In Your Buy-and-Hold Portfolio

By Divya Premkumar, InvestorPlace Contributor Feb 4, 2021

Investing in stocks that show long-term potential is a tried and true way to earn some long-term gains. Here’s a look at seven growth stocks worth buying this year.

The Best 4 Pharmaceutical Stocks to Buy in Any Climate

By Joel Baglole Jan 22, 2021

Pharmaceutical stocks, such as Moderna and Novavaxsaw their share prices more than double in the last year. However, not all pharmaceutical stocks have their wagons hitched to solving the Covid-19 pandemic. There are many pharmaceutical stocks that are great long-term investments and would be good additions to a portfolio in any environment. Here we look at four such pharmaceutical stocks.

Biden Stocks: 16 Stocks to Watch for a Defense Production Act Boost

By Sarah Smith, Editor, Today's Market Jan 21, 2021

Biden stocks like APT stock, KODK stock, MMM stock and CAH stock are all ones to watch thanks to the Defense Production Act.

4 Top Stock Trades for Thursday: AMZN, PLUG, GME, REGN

By Bret Kenwell, InvestorPlace Contributor Jan 13, 2021

Amazon, Plug Power, GameStop and Regeneron were our top stock trades for Thursday. Let's have a look at the charts after some big moves.

7 Short-Term Stocks To Buy for a Happy New Year

By Chris Lau, InvestorPlace Contributor Dec 23, 2020

Investors already enjoying strong gains in the year may want to look at these short-term stocks to buy heading into the new year.

4 Pharmaceutical Stocks That Aren’t Worth Their Outsized 2020 Gains

By Joel Baglole Dec 1, 2020

Now that companies such as Pfizer, Moderna and AstraZeneca have emerged with viable vaccines against Covid-19, the hype around many pharmaceutical stocks is fading. Here are four stocks investors should be weary of in the weeks ahead.

Pfizer, Moderna Lead the Vaccine Race: Here’s Where 7 Other Top Vaccine Stocks Stand

By Josh Enomoto, InvestorPlace Contributor Nov 24, 2020

As Pfizer and Moderna take the lead in the novel coronavirus vaccine race, here’s how this affects other Covid-19-related biotech stocks.

REGN Stock: 11 Things for Investors to Know About Regeneron Approval

By Sarah Smith, Editor, Today's Market Nov 23, 2020

REGN stock is shifting the market today thanks to news its coronavirus treatment received emergency FDA approval.

7 Pharmaceutical Stocks to Buy for 2021 and Beyond

By Bret Kenwell, InvestorPlace Contributor Nov 17, 2020

Pharmaceutical stocks help make the world go round. Without them, common ailments would plague our lives. With them, we can solve Covid-19.

4 Top Biotech Stocks to Buy for Operation Warp Speed

By Joel Baglole Nov 3, 2020

The U.S. government has pulled out all the stops to develop a treatment for Covid-19. These biotech stocks are leading the race for a cure.

7 Cutting-Edge Biotech Stocks for Tomorrow

By Bret Kenwell, InvestorPlace Contributor Oct 28, 2020

Biotech stocks are always going to be here, in good times and bad. Let's look at a few that are worth considering on the long side.

7 Highly Rated Pharmaceutical Stocks for Q4

By Joel Baglole Oct 12, 2020

Investors are banking on an upsurge in pharmaceutical stocks once various vaccines and other therapies gain commercial approval from the U.S. Food and Drug Administration (FDA). Here is a list of pharmaceutical companies that stand to benefit in the coming months.